Enrolling
CTNPT 035: Vitamin D and NAFLD in people living with HIV
Association of vitamin D insufficiency with non-alcoholic fatty liver disease in HIV mono-infected patients
Learn MoreEnrolling
Association of vitamin D insufficiency with non-alcoholic fatty liver disease in HIV mono-infected patients
Learn MoreStart-up
Falls in older persons with HIV: Frequency, risk factors and feasibility of a future interventional trial
Learn MoreCompleted
Exploring the role of the soluble glycoprotein 120 as a pan-toxin driving immune dysfunction and accelerated aging in people living with HIV
Learn MoreStart-up
Promoting Mental Health and Reducing HIV Risk Behaviours through Self-compassion, Mindful Acceptance & Resilience Transformation (SMART): An Evidence-informed Pilot Randomized Trial with Diaspora MENA Gay, Bisexual and Trans Youth in Ontario
Learn MoreEnrolling
Placebo-controlled randomized trial of tecovirimat in non-hospitalized patients with Mpox: Canadian Feasibility Study
Learn MoreEnrolling
A Study of Reduced Dosing of the Nonavalent HPV Vaccine in Women Living with HIV
Learn MoreOngoing
A learning health system to improve care in people living with HIV
Learn MoreOngoing
Perception of menopausal hormone therapy amongst women living with HIV: A feasibility study for a future randomized controlled trial
Learn MoreEnrolling
CTN Trials have been approved by the Community Advisory Committee of the Canadian HIV Trials Network and the Network’s Scientific Review Committee, or other national peer-review panels such as those at the Canadian Institutes of Health Research and the U.S. National Institutes of Health. CTNPT studies are small-scale investigations designed to determine the feasibility of research concepts, and do not all go through the regular CTN clinical trial review process. For information on the benefits and risks of participating in HIV clinical trials, call CATIE toll-free at 1-800-263-1638.